ANAB logo

ANAB

AnaptysBio Inc.

$21.40
+$0.56(+2.69%)
45
Overall
--
Value
45
Tech
--
Quality
Market Cap
$583.46M
Volume
457.35K
52W Range
$12.21 - $38.67
Target Price
$49.55
Order:

Income Statement

MetricTrendChart
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$10.0M$5.0M$8.0M$75.0M$63.2M$10.3M$17.2M$91.3M
Total Revenue
$10.0M$5.0M$8.0M$75.0M$63.2M$10.3M$17.2M$91.3M
GROSS PROFIT
Gross Profit
$10.0M$5.0M$8.0M$75.0M$63.2M$10.3M$17.2M$91.3M
OPERATING EXPENSES
Operating Expenses
$-38.8M$-71.7M$115.4M$98.9M$120.0M$125.4M$181.6M$206.2M
Research & Development
$29.4M$56.2M$99.3M$80.0M$98.5M$88.8M$139.6M$163.8M
Research Expense
$29.4M$56.2M$99.3M$80.0M$98.5M$88.8M$132.3M$163.8M
Selling, General & Administrative
$9.3M$15.5M$16.1M$18.9M$21.5M$36.6M$41.9M$42.4M
General & Administrative Expenses
$9.3M$15.5M$16.1M$18.9M$21.5M$36.6M$41.9M$42.4M
Salaries & Wages
----------$27.4M$33.2M$34.0M
Other Operating Expenses
$-182.0K$-1.2M$-1.2M$-898.0K$-984.0K$-896.0K$-1.5M$-1.9M
OPERATING INCOME
Operating income
$-38.8M$-66.7M$-107.4M$-23.9M$-56.8M$-115.2M$-164.4M$-114.9M
EBITDA
$-28.1M$-61.1M$-98.6M$-18.3M$-54.3M$-105.3M$-161.2M$-142.8M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$1.8M$1.7M$1.0M--$1.4M$21.1M$18.1M--
Intinc
$1.6M$6.7M$11.0M$4.0M$431.0K$7.5M$18.9M$19.8M
Net Non-Operating Interest Income/Expense
$-152.0K$5.0M$9.9M$4.0M$431.0K$13.6M$18.9M$19.8M
Other Income/Expense
$-8.9M$159.0K$-1.0K$11.0K$1.4M$12.0K$2.0K$-14.0K
Other Special Charges
$8.9M$-159.0K$1.0K$-11.0K$-1.4M$12.0K$-2.0K$14.0K
PRE-TAX INCOME
EBIT
$-28.3M$-60.2M$-96.4M$-19.9M$-56.3M$-107.6M$-163.6M$-145.2M
Pre-Tax Income
$-30.1M$-61.8M$-97.5M$-19.9M$-57.8M$-128.7M$-163.6M$-145.2M
INCOME TAX
Tax Provision
$-7.6M$-192.0K$-152.0K$-21.0K$-142.0K$24.0K$-4.0K$3.0K
NET INCOME
Net Income
$-30.1M$-61.7M$-97.3M$-19.9M$-57.8M$-128.7M$-163.6M$-145.2M
Net Income (Continuing Operations)
$-30.1M$-61.7M$-97.3M$-19.9M$-57.8M$-128.7M$-163.6M$-145.2M
Net Income (Discontinued Operations)
$-30.1M$-61.7M$-97.3M$-19.9M$-57.8M$-128.7M$-163.6M$-145.2M
Net Income (Common Stockholders)
$-30.1M$-61.7M$-97.3M$-19.9M$-57.8M$-128.7M$-163.6M$-145.2M
Normalized Income
--------------$-143.8M
TOTALS
Total Expenses
$-38.8M$-71.7M$115.4M$98.9M$120.0M$125.4M$181.6M$206.2M
SHARE & EPS DATA
Average Shares Outstanding
$19.8M$24.7M$27.1M$27.3M$27.4M$28.2M$26.9M$28.4M
Average Shares Outstanding (Diluted)
$19.8M$24.7M$27.1M$27.3M$27.4M$28.2M$26.9M$28.4M
Shares Outstanding
$23.8M$27.0M$27.3M$27.4M$28.0M$27.9M$26.8M$30.7M
Basic EPS
$-1.52$-2.5$-3.6$-0.73$-2.11$-4.57$-6.08$-5.12
Basic EPS (Continuing Operations)
----$-3.6$-0.73$-2.11$-4.57$-6.08$-5.12
Diluted EPS
$-1.52$-2.5$-3.6$-0.73$-2.11$-4.57$-6.08$-5.12
Diluted EPS (Continuing Operations)
----$-3.6--$-2.11$-4.57$-6.08$-5.12
OTHER METRICS
Development Expense
------------$7.3M--
Gain On Sale Of P P E
------$100.0K--------
Other Gand A
$9.3M$15.5M$16.1M$18.9M$21.5M$36.6M$41.9M$42.4M
Rent And Landing Fees
$9.3M$15.5M------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2ANAB$21.40+2.7%457.35K
3
4
5
6

Get AnaptysBio Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.